InvestorsHub Logo

BNP31

11/12/18 10:10 AM

#2380 RE: Renegades17 #2379

Management needs to step up now. Shares moving from restricted to float with no interjection from management to help provide bid support. They need to do better.

FELLER

11/12/18 10:13 AM

#2382 RE: Renegades17 #2379

Based on the other email addresses, I assume Alex Wasyl would be awasyl@nexienbiopharma.com... Reach out.

He may have a shareholder update planned soon. Who knows. Obviously they won't tell you any material updates.